The therascreen FGFR RGQ RT-PCR Kit is a CDx test to help identify patients with urothelial cancer for whom treatment with BALVERSA (erdafitinib) may be appropriate.

The therascreen PIK3CA RGQ PCR Kit is a CDx test to help identify patients with advanced breast cancer for whom treatment with PIQRAY (alpelisib) may be appropriate.

The therascreen KRAS RGQ PCR Kit is a CDx test to help identify patients with NSCLC for whom treatment with LUMAKRAS (sotorasib) may be appropriate.